CON vs PSA · P/E 18, rev $1.90B vs rev $4.82B
Concentra Group Holdings Parent, Inc. (CON) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Concentra Group Holdings Parent, Inc. (CON) is a medical care facilities company listed on US.
PSA (PSA) common stock.
Latest reported CON revenue for 2024-12-31 was $1.90B. Net income was $171.9M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. CON currently screens at market cap $3.18B and trailing P/E 17.9.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CON currently screens at market cap $3.18B and trailing P/E 17.9. PSA currently screens at market cap $0.
Not investment advice. Open the CON and PSA stock pages for the full models.
Not investment advice.